John W. Kitchens, MD, and Sara LeMay, OD, discuss strategies for improving care of patients with diabetic eye disease, starting with imaging. Drs. Kitchens and LeMay review the benefits of ultra-widefield imaging and the importance of communication about imaging findings between eye care providers and timing of referrals.
Improving Outcomes and Coordinating Care in Diabetic Retinopathy and Diabetic Macular Edema
Media formats available:
Details
Presenters
Target Audience
This certified continuing medical education activity is designed for retina specialists, optometrists, and comprehensive ophthalmologists involved in the care of patients with retinal diseases.
Grantor Statement
This activity is supported by an unrestricted educational grant from Regeneron.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Develop joint strategies for pre- and posttreatment management of patients with DR/DME to improve outcomes
- Coordinate referral and comanagement practices between primary eye care and retina to streamline care processes for patients with DR/DME
Accreditation and Credit Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this an eduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Sponsored by
Evolve Medical Education LLC is a COPE-accredited administrator.
This activity, COPE Activity Number 131119, is accredited by COPE for continuing education for optometrists. This course is approved for 0.25 hour of CE.
Course #: 98938-TD
Activity #: 131119COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Faculty
John W. Kitchens, MD
Partner
Retina Associates of Kentucky
Lexington, KY
Sara LeMay, OD
Retina Associates of Kentucky
Ashland, KYDisclosure of Relevant Financial Relationships
DISCLOSURE POLICY
In accordance with the ACCME/COPE Standards for Integrity and Independence , it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.
John W. Kitchens, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory Board: Alcon, Apellis Pharmaceuticals, Astellas, Bayer, Carl Zeiss Meditec, EyePoint Pharmaceuticals, Genentech, Harrow, Neurotech Pharmaceuticals, Opthea, Outlook, Regeneron, and Vortex.Consultant: Alcon, AbbVie, Apellis Pharmaceuticals, Astellas, Bayer, Carl Zeiss Meditec, EyePoint Pharmaceuticals, Genentech, Harrow, Neurotech Pharmaceuticals, Opthea, Outlook, and Regeneron. Speaker's Bureau: Apellis Pharmaceuticals, Astellas, Bayer, Genentech, and Regeneron.
Sara LeMay, OD, has had no financial relationships or affiliations with ineligible companies.
The Evolve staff, planners and peer reviewerhave no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals, Inc.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
John W. Kitchens, MD
Sara LeMay, OD
Sunir J. Garg, MD, FACS, FASRS
Charles C. Wykoff, MD, PhD, FACS
- CME/CE Broadcast Replay
The Comanagement Plan: Elevating Retinal Care Through Unified Vision
1.00 creditSunir J. Garg, MD, FACS, FASRS
John W. Kitchens, MD
Sara LeMay, OD
Charles C. Wykoff, MD, PhD, FACS
Justis P. Ehlers, MD, FASRS
Roger A. Goldberg, MD, MBA
Jennifer, I. Lim, MD, FASRS, FARVO
Ehsan Rahimy, MD
